Annual report pursuant to Section 13 and 15(d)

PF MEDICAL (Details Narrative)

v3.23.1
PF MEDICAL (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Loss on deconsolidation of subsidiary $ 1,062,000  
Legal and accounting costs   $ 94,000  
Sales Agreement [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Acquired price 10    
Non-controlling interest 1,004,000    
Loss on deconsolidation of subsidiary $ 902,000    
Sales Agreement [Member] | PFM LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Ownership percentage     60.54%
Notes receivable, amount     $ 47,000
Trade payables     $ 2,537,000